AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 1 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2012. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $727,000 | -52.7% | 205,876 | +11.8% | 0.85% | -38.0% |
| Q2 2014 | $1,538,000 | +206.4% | 184,181 | +132.8% | 1.38% | +64.5% |
| Q1 2014 | $502,000 | -11.3% | 79,131 | -0.4% | 0.84% | +112.7% |
| Q4 2013 | $566,000 | +258.2% | 79,451 | +276.5% | 0.39% | +103.6% |
| Q3 2013 | $158,000 | +29.5% | 21,100 | 0.0% | 0.19% | +62.2% |
| Q2 2013 | $122,000 | +60.5% | 21,100 | 0.0% | 0.12% | +83.1% |
| Q4 2012 | $76,000 | -20.8% | 21,100 | 0.0% | 0.06% | -16.7% |
| Q1 2012 | $96,000 | – | 21,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |